ADIPOQ and prostate carcinoma: This was further proven in a prospective analysis of the Physicians’ Health Study that found no association between adiponectin concentration and overall risk of prostate cancer, but men with higher adiponectin concentrations had a lower risk of developing high grade prostate cancer and lower risk of dying from the disease [80].